IN.PACT AV access trial meets primary safety and effectiveness endpoints
Medtronic has announced the first-ever results from the IN.PACT AV access clinical study comparing the investigational IN.PACT AV drug-coated balloon (DCB) to percutaneous transluminal angioplasty (PTA) in patients with de novo or non-stented restenotic arteriovenous (AV) fistulae lesions. The study met primary safety and effectiveness endpoints and data were presented today at the Cardiovascular and … Continue reading IN.PACT AV access trial meets primary safety and effectiveness endpoints
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed